Dear Directors and Managers The Stock Exchange of Thailand, C.I. Group Public Company Limited (“the company”) hereby reports financial performance for the first half ended June 30, 2020 as follows

last year Dear Directors and Managers The Stock Exchange of Thailand, C.I. Group Public Company Limited (“the company”) hereby reports financial performance for the period of 9 month ended September 30

····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ····················›››››››››››››››››--------::::::::::::::::::::::::::::::///////////////············››››››››››››››››››››› ···...

. Administrative expenses were Baht 68.49 million, increased Baht 7.18 million or 11.71 % from the same period of last year. This is result from increasing in normally administration such as increasing in staff cost

previous year as a result of a decrease in sales. Total cost of sales and administration were 146.39 million Baht, it has decreased from the same period of previous year amounting 3.97 million Baht or

normal administration. 6. Finance cost was Baht 13.65 million; increased Baht 2.42 million or 21.51% from the same period of last year. This is the result from increasing in short term loans from financial

is result from increasing in normal administration. 6. Finance cost was Baht 15.68 million; increased Baht 4.49 million or 40.13% from the same period of last year. This is the result from increasing

Bangkok, January 6, 2015 - The Securities and Exchange Commission, Thailand (SEC) and the National Institute of Development Administration (NIDA) signed a memorandum of understanding (MOU) to form

Syndicate Public Company Limited (the “Company”) and its subsidiaries hereby submit the Annual Financial Statements, ending September 30, 2018 and 2017, together with the clarification of the performance of

to decreasing in selling and administration expenses and gain on change in fair value less cost of sale of biological assets. Page 3/…… - 3 - Financial Position Asset As of 30 June 2020, the company